COMP <GO>
ARTW vs TMO // FORWARD P/E MULTIPLE
Art's-Way Manufacturing Co. Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ARTW 2
— TMO 10
▲ FORWARD P/E MULTIPLE LEADER: ARTW
LAST: $2.71 (-10.23%) • MKT CAP: $15.7M
forward-pe
14.1x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARTW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARTW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 27.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.50% | 9.30% | -7.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.9x | 30.4x | -8.50 | ARTW | /valuation <GO> |
| Free Cash Flow Yield | -9.75% | 2.40% | -12.15 | TMO | /fcf-yield <GO> |
| Operating Margin | 1.30% | 17.40% | -16.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 15.10% | -10.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -6.20% | 3.90% | -10.10 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.06 | 4.50 | -1.44 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.2 | 62.9 | -14.70 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 14.1x | 36.3x | -22.20 | ARTW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.7M | $262.22B | -$262.20B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARTW REV | TMO REV | ARTW GROSS % | TMO GROSS % | ARTW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.0M | $44.56B | 27.3% | — | -$1.5M | $6.29B |
| FY 2024 | $24.5M | $42.88B | 29.8% | — | $1.9M | $7.27B |
| FY 2023 | $30.3M | $42.86B | — | — | -$55.2K | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARTW // BETA —
TMO // BETA 0.94